3 results match your criteria: "University-Hospital Gemelli IRCSS[Affiliation]"
Vacuum Erection Device Plus Once-Daily Tadalafil Improve Clinical Outcomes after Extracorporeal Shock Wave Therapy in Men Affected by Erectile Dysfunction Associated with Peyronie's Disease.
Life (Basel)
September 2024
Department of Emergency, University-Hospital Gemelli IRCSS, 00168 Roma, Italy.
Article Synopsis
- This study investigates the effectiveness of combining vacuum erection devices (VEDs) with PDE5 inhibitors like Tadalafil to improve results after extracorporeal shockwave therapy (ESWT) in men with erectile dysfunction stemming from Peyronie's disease.
- A total of 153 patients were divided into two groups: one received both VEDs and Tadalafil, while the other only received Tadalafil with ESWT.
- Results showed that the group using VEDs experienced significant improvements in penile curvature, pain during erections, and overall erectile function, with effects observed at 3, 6, and 12 months post-treatment.
Multimodal treatments based on Tadalafil during acute phase of Peyronie's disease: experience at two referral academic centers.
Ir J Med Sci
October 2024
Department of Emergency, University-Hospital Gemelli IRCSS, Rome, Italy.
Article Synopsis
- The study aims to evaluate the effectiveness of daily Tadalafil 5 mg combined with non-surgical treatments like intra-plaque verapamil injections, vacuum erection devices, or shockwave therapy in patients with acute Peyronie's disease.
- A total of 445 men were divided into four groups, each receiving different treatment combinations for 3 to 12 weeks, with assessments of erectile dysfunction, pain, plaque size, and curvature at multiple intervals.
- Results showed that while there were no significant differences at the start, after one year, the group receiving shockwave therapy showed notable improvements in penile curvature and pain during erections, indicating that multimodal therapy can enhance quality of life for these patients.*
Transrectal Prostate Biopsy Approach in Men Undergoing Kidney Transplant: A Retrospective Cohort Study at Three Referral Academic Centers.
Diagnostics (Basel)
January 2024
Department of Emergency, University-Hospital Gemelli IRCSS, 00168 Roma, Italy.
Background: Currently, there are no studies evaluating the feasibility of a prostate biopsy approach in men undergoing a kidney transplant (KT). Owing to this evidence, we planned a retrospective population-based study to evaluate our experience of a transrectal prostate biopsy (TR-PB) approach and studied the impact on the complication rate and outcomes in patients undergoing KT with suspected prostate cancer (PCa).
Methods: We collected data from KT patients who underwent PB with a transrectal approach.